During the past decade, Pacific Research Network conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 38 clinical trials were completed, i.e. on average, 59.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 34 clinical trials were completed. i.e. 125.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pacific Research Network" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Eisai Inc." with 6 trials sponsored, "Jazz Pharmaceuticals" with 6 trials sponsored, "Biogen" with 5 trials sponsored and "Bristol-Myers Squibb" with 5 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pacific Research Network" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Alzheimer's Drug Discovery Foundation" with 1 trials as a collaborator and "Amsterdam UMC, location VUmc" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Pacific Research Network" are "Alzheimer's Disease" (34 trials), "Alzheimer Disease" (18 trials), "Narcolepsy" (6 trials), "Obstructive Sleep Apnea" (6 trials) and "Idiopathic Hypersomnia" (3 trials). Many other conditions were trialed in "Pacific Research Network" in a lesser frequency.

Most popular intervention types in "Pacific Research Network" are "Drug" (92 trials), "Other" (8 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (53 trials), "JZP-110" (4 trials), "placebo" (4 trials), "Donanemab" (3 trials) and "Lanabecestat" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pacific Research Network" are 95 trials for "All" genders.

Currently, there are NaN active trials in "Pacific Research Network". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 63 completed trials in Pacific Research Network, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Pacific Research Network, 10 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".